Cronos (CRON) stock
CRON · Cronos Group Inc. · NASDAQ
- Market cap
- $1.11B
- EPS (TTM)
- $0.16
- Shares out
- 366.5M
What is the latest news on CRON stock?
Veteran U.S. Diplomat Dr. Eugene Bae and Seasoned Public Company CFO Jim Rudyk Join the Board; David Hanick and Andrew Frazer to Step Down Effective December 31, 2026 Almonty Industries Inc. ("Almonty" or the "Company") (NASDAQ:ALM) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today announced the appointment of Dr. Eugene Bae, Ph.D., and James (Jim) Rudyk, CPA, CA, to its Board of Directors (the "Board") as independent directors, effective immediately, and that David Hanick and Andrew Frazer will step down from the Board effective December 31, 2026. The Company also announced its intention to pursue a listing on the Korea Exchange ("KRX") in South Korea, home to A
All CRON newsWhen does Cronos report earnings?
Cronos last reported on Nov 5, 2026, the date it announced on Oct 8, 2026. Before that it reported on Aug 6, 2026 and May 11, 2026. On that schedule the next report would come around early February 2027, with the date usually announced about 3 weeks ahead.
CRON earnings historyWho owns the most CRON stock?
D. E. Shaw & Co., Inc. was the largest reported holder of CRON at the end of Q2 2026, with 8,840,503 shares worth $24.6 million. Next came Chescapmanager LLC ($22.1 million) and Tidal Investments LLC ($10.5 million). In all, 194 institutions reported $133.7 million of CRON in their 13F filings.
All CRON fund holdersFinancial highlights
Full financials- Revenue, TTM
- $271.85M
- Revenue growth
- +54.3%
- Net income, TTM
- $63.36M
- Net margin
- 23.3%
- Free cash flow, TTM
- $65.38M
- Cash
- $411.19M
For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.
Latest news
25 items- PRAlmonty Strengthens Board with Two Independent Directors and Announces Intention to Pursue a Secondary Listing on the Korean ExchangeVeteran U.S. Diplomat Dr. Eugene Bae and Seasoned Public Company CFO Jim Rudyk Join the Board; David Hanick and Andrew Frazer to Step Down Effective December 31, 2026 Almonty Industries Inc. ("Almonty" or the "Company") (NASDAQ:ALM) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today announced the appointment of Dr. Eugene Bae, Ph.D., and James (Jim) Rudyk, CPA, CA, to its Board of Directors (the "Board") as independent directors, effective immediately, and that David Hanick and Andrew Frazer will step down from the Board effective December 31, 2026. The Company also announced its intention to pursue a listing on the Korea Exchange ("KRX") in South Korea, home to A
- INSIDEROfficer Wagner Adam converted options into 20,242 shares, increasing direct ownership by 19% to 124,229 units (SEC Form 4)4 - Cronos Group Inc. (0001656472) (Issuer)
- SECSEC Form 10-Q filed by Cronos Group Inc.10-Q - Cronos Group Inc. (0001656472) (Filer)
- SECCronos Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Cronos Group Inc. (0001656472) (Filer)
- PRCronos Group Reports 2026 Third Quarter ResultsOrganically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q3 2026 increased by 73% year-over-year on an organic, constant-currency basis Generated record net revenue in Canada, with Spinach® maintaining #1 market share in vapes and edibles1 Eleventh consecutive quarter of record net revenue in Israel, where PEACE NATURALS® remains the #1 cannabis brand2 Delivered record net revenue in Germany TORONTO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company"), today announced its 2026 third quarter business results. "Cronos organically achieved records across net revenue, gross pr
- INSIDERSEC Form 4 filed by Cronos Group Inc.4 - Cronos Group Inc. (0001656472) (Issuer)
- INSIDERSEC Form 3 filed by Cronos Group Inc.3 - Cronos Group Inc. (0001656472) (Issuer)
- SECSEC Form 8-K filed by Cronos Group Inc.8-K - Cronos Group Inc. (0001656472) (Filer)
- PRCronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis CompanyCronos acquires CanAdelaar for a base purchase price of €57.5 million plus cash earnout of 0.5x Normalized EBITDA1 in 2026 and 2027 Establishes Cronos’ European platform with #1 market share2 in the largest adult-use cannabis market in Europe3 Enables borderless product strategy, leveraging investments in genetics, R&D, and product development TORONTO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company"), an innovative global cannabis company, today announced that it has completed its previously announced acquisition of CanAdelaar B.V. ("CanAdelaar"), the largest cannabis company operating within the Netherlands’ adult-use cannabis pil
- PRFan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall SeasonTORONTO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos"), an innovative global cannabis company, announced today that for the third consecutive year it is bringing back its popular limited-edition Caramel Green Apple flavor to its best-selling lineup of SOURZ by Spinach® edibles. For the first time, this seasonal flavor will launch exclusively in the SOURZ by Spinach® Fully Blasted 10-pack, the #1 edible multipack in Canada1. The brand is also welcoming back the popular Spinach® Sweet Green Apple 1g vape that first launched in 2025. This limited-edition flavor bolsters a best-selling lineup of 1g vapes with unique cannabinoid ratios and flavor combi
- PRCronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2026 third quarter earnings conference call on Thursday, November 5, 2026, at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay
- PRCronos Hosts 2026 Investor DayTORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos"), an innovative global cannabis company, is hosting its first Investor Day today, September 24, 2026, at its Cronos Growing Company Inc. Kingsville location. Presentation materials can be accessed on the Company’s Investor Relations website under Events & Presentations at: https://ir.thecronosgroup.com/events-presentations The session will be webcast today starting at 12:00 p.m. ET. Webcast registration is now open at: https://dpregister.com/sreg/10211885/104dd78be04. After the event, a recording of the webcast will be archived for replay on the Company’s website at: https://ir.thecronosgr
- PRCronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, OntarioTORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos"), an innovative global cannabis company, will host its first Investor Day on Thursday, September 24, 2026, at its Growing Company ("Cronos GrowCo") Kingsville location. "We’re excited to host our first Cronos Investor Day from our Kingsville, Ontario, Cronos GrowCo location. This facility is at the center of how we’ve been scaling production, driving efficiency, and building the product pipeline that’s fueling our growth in Canada and internationally," said Mike Gorenstein, Chairman, President and CEO of Cronos. The session will be webcast on September 24 at 12:00 p.m. ET and will include: A
- SECCronos Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Cronos Group Inc. (0001656472) (Filer)
- PRCronos’ brand Spinach® Expands its Best-Selling Lineups of Edibles and VapesTORONTO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos"), an innovative global cannabis company, is expanding its lineup of edible multipacks with the SOURZ by Spinach® Blue Raspberry Lemonade Fully Blasted multipack, featuring its first live resin gummy. This month the brand will also launch new flavors in its best-selling lineup of vape cartridges, Strawberry Banana and Sweet Citrus Punch. The new SOURZ by Spinach® Blue Raspberry Lemonade Fully Blasted gummies will be exclusively sold in the SOURZ by Spinach® Fully Blasted 10-pack, Canada’s No. 1 edible multipack as of June 20261. The popular Blue Raspberry Lemonade flavor features the same bold
- INSIDERSEC Form 4 filed by Director Garnick Murray R4 - Cronos Group Inc. (0001656472) (Issuer)
- INSIDERSEC Form 4 filed by Director Rudyk James Daniel4 - Cronos Group Inc. (0001656472) (Issuer)
- INSIDERSEC Form 4 filed by Director Adler Jason Marc4 - Cronos Group Inc. (0001656472) (Issuer)
- SECAmendment: Cronos Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K/A - Cronos Group Inc. (0001656472) (Filer)
- SECSEC Form 10-Q filed by Cronos Group Inc.10-Q - Cronos Group Inc. (0001656472) (Filer)
- SECCronos Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Cronos Group Inc. (0001656472) (Filer)
- PRCronos’ SOURZ by Spinach® Expands its Lineup of EdiblesTORONTO, July 21, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos"), an innovative global cannabis company, is expanding its lineup of SOURZ by Spinach® Fully Blasted multipacks to meet consumer demand for edible products during the summer season. The lineup of SOURZ by Spinach® Fully Blasted multipacks with liquid diamond-infused gummies now includes the brand’s popular flavors featuring rare cannabinoid formulations, along with a new limited-time offer (LTO) flavor for the summer months. SOURZ by Spinach® Fully Blasted multipacks are the #1 edible multipack in Canada, capturing 31.7% share of all 10x10 pack sales in May 2026¹. The Spinach® brand continues to
- PRCronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026TORONTO, July 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2026 second quarter earnings conference call on Thursday, August 6, 2026 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay o
- PRCronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in CanadaTORONTO, June 30, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. ("Cronos" or the "Company") (NASDAQ:CRON) (TSX:CRON), an innovative global cannabis company, announced today that it has appointed ATB Capital Markets Corp. ("ATB Cormark") to act as its broker in connection with share repurchases over the facilities of the TSX or other alternative Canadian trading systems, in place of Virtu Canada Corp., under its previously announced share repurchase program. About Cronos Cronos is a global cannabis company focused on scaling leading consumer goods products through research and development and innovation. With a passion to responsibly elevate the consumer experience, Cronos is building an ico
- INSIDERSEC Form 3 filed by new insider Broughton Darren Chester3 - Cronos Group Inc. (0001656472) (Issuer)
CRON rankings
- Other4(27%)
- SEC Filings4(27%)
- Insider3(20%)
- Earnings2(13%)
- M&A1(7%)
- Leadership1(7%)
Cronos Group Inc. (CRON) is a Medicinal Chemicals and Botanical Products company listed on NASDAQ. In the last 30 days Quantisnow tracked 5 wire items for CRON, including 2 SEC filings, 1 earnings update and 1 insider trade. The most recent was published Nov 17, 2026.
CRON FAQ
9 questionsWhat does Cronos Group Inc. do?
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness...What is CRON revenue?
Cronos Group Inc. (CRON) reported $271.85M of revenue for the twelve months ended Sep 30, 2026. That is up 54.3% from the year before. Revenue for fiscal 2025 was $193.36M.Is CRON profitable?
Yes. Cronos Group Inc. earned $63.36M in net income for the twelve months ended Sep 30, 2026, a net margin of 23.3%.How much cash and debt does CRON have?
Cronos Group Inc. reported $411.19M in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does CRON stock trade?
Cronos Group Inc. (CRON) is listed on NASDAQ.What sector and industry is CRON in?
Cronos Group Inc. operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.What are analysts saying about CRON?
Across the last 8 analyst actions on Cronos Group Inc., there were 3 upgrades and 0 downgrades. The most recent action was from Canaccord Genuity: Buy on 2026-01-27. Recent price targets range from $3.00 to $4.25.What companies are similar to CRON?
Notable peers in the same industry include TLRY (Tilray Brands Inc.), CGC (Canopy Growth Corporation), ACB (Aurora Cannabis Inc.), YCBD (cbdMD Inc.). Compare CRON side-by-side with any of them on Quantisnow.How can I track CRON on Quantisnow?
Quantisnow aggregates Cronos Group Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CRON to receive live email and push alerts on every new disclosure.
Is something on this page wrong, or out of date? Request a change